FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
1,872 letters match. Newest first.
-
DevicesJiangsu Kerbio Medical Technology Group Co.
FDA cites Jiangsu Kerbio Medical Technology Group for serious GLP violations in medical device safety testing.
High risk -
DevicesCCIC Huatongwei International Inspection Co., Ltd.
FDA warns CCIC Huatongwei after inspection found copied data and missing records in medical device safety tests.
High risk -
AnimalMeds For Vets, LLC
Meds For Vets compounded unapproved animal drugs from bulk substances and failed manufacturing quality rules, including sterility controls.
High risk -
DrugsAnhui Hanbon Daily Chemical Co., Ltd.
FDA warns Anhui Hanbon Daily Chemical over CGMP failures in OTC drugs, including use of an incorrect excipient and untested ingredients.
High risk -
AnimalBoothwyn Pharmacy LLC
FDA warns Boothwyn Pharmacy over unapproved compounded animal drugs and falsified endotoxin records.
High risk -
FoodChaohu Daxin Foodstuffs Co., Ltd.
FDA warns Chaohu Daxin Foodstuffs that its ready-to-eat cooked crawfish from China is adulterated due to an inadequate seafood HACCP plan and poor sanitation.
High risk -
DrugsABBE Laboratories, Inc.
FDA warns ABBE Laboratories over manufacturing failures for over-the-counter topical drugs, including ingredient testing.
High risk -
DrugsK & Care Organics
FDA warns K & Care Organics over unapproved over-the-counter (OTC) foam sunscreen drugs sold in the U.S. without required authorization.
High risk -
DrugsConfer With
FDA told London-based Confer With that its Vivant True Tone skin-lightening serum is an unapproved drug sold without FDA approval.
High risk -
DevicesSpectra Therapy, LLC
FDA warns Spectra Therapy over LASERwrap infrared lamp device quality-system violations and unapproved disease-treatment claims.
High risk -
DrugsGussyup LLC dba Private Label Grooming
FDA found Gussyup LLC, a Henderson, Nevada OTC drug maker, lacking quality oversight and ingredient identity testing; company stopped drug production.
High risk -
FoodTKO Distribution, LLC
FDA warned TKO Distribution that its Delta-8 THC gummy products are adulterated because Delta-8 THC is an unsafe food additive.
High risk -
FoodOrchid Grocery
FDA says Orchid Grocery did not have required foreign supplier verification for imported sesame seeds, supplement and fish masala.
Medium -
DrugsOasis Medical, Inc.
FDA cites Oasis Medical for current good manufacturing practice violations in sterile ophthalmic drugs, including particulate contamination and unresolved sterility failures.
High risk -
DevicesMectronic Medicale S.R.L.
FDA warns Mectronic Medicale over quality system failures and uncleared marketing of therapeutic RF/laser devices.
High risk -
DrugsShiva Analyticals Private Limited
FDA warned Shiva Analyticals, an Indian contract drug testing lab, that inadequate OOS investigations and data integrity failures adulterated tested drugs.
High risk -
DevicesOnkos Surgical, Inc.
FDA warns Onkos Surgical over ELEOS implant system cleaning, corrective-action, risk, sampling, and removal-reporting failures.
High risk -
DrugsKabana Skin Care LLC
Kabana Skin Care failed to test OTC drug ingredients and finished products, prompting a recall and halt of U.S. drug manufacturing.
High risk -
Drugswww.mysteroidsmarket.com
FDA warns Israel-based website mysteroidsmarket.com for selling unapproved and misbranded stimulants and benzodiazepines to U.S. consumers.
High risk -
Drugswww.portmeds.com
FDA warned www.portmeds.com for selling unapproved, misbranded opioids, benzodiazepines, and Schedule II stimulants online without prescriptions.
High risk -
Drugswww.plakini-pharma.com
FDA warned Malaysia-based website plakini-pharma.com for selling unapproved, misbranded opioids, benzodiazepines, and stimulants to U.S. consumers.
High risk -
DrugsMacsen Drugs
FDA cites Macsen Drugs for releasing fire-exposed APIs and inadequate stability data at India plant.
High risk -
DevicesLeltek Inc.
FDA warns Leltek over quality-system failures for LU700 and LK128 ultrasound systems, including corrective actions, complaints, records, and adverse-event reporting.
Medium -
DrugsGlenmark Pharmaceuticals Limited
FDA warns Glenmark over unresolved dissolution failures and inadequate investigations at its Pithampur, India drug plant.
High risk -
DrugsMedical Chemical Corporation
FDA warned Medical Chemical Corp over manufacturing violations, unapproved Tincture Green Soap, and improper drug listing.
High risk -
BiologicsO3UV, LLC
FDA warns O3UV that its Champion and EBOO ozone/UV blood devices are unapproved, misbranded, and made without required quality controls.
High risk -
DrugsNature’s Fusions LLC
FDA cited Nature's Fusions for over-the-counter hand sanitizer manufacturing with inadequate stability, component and finished-product testing, and water controls.
High risk -
FoodIndulgeRx Brands, Inc
FDA says IndulgeRx's FightBack nut butters are unapproved new drugs because website and label claims target cancer and disease.
Medium -
DevicesWHOOP, Inc.
FDA warns WHOOP it markets Blood Pressure Insights without device clearance or approval.
High risk -
DrugsScope Health Inc
FDA says Scope Health sold unapproved OTC eye drugs online and misbranded several products.
High risk -
DrugsRevitalize Energy, Inc.
FDA warned Revitalize Energy that its Revitalize Energizing Eye Drops are an unapproved new drug and misbranded.
High risk -
DrugsDaewoo Pharmaceutical Co., Ltd.
FDA warns Daewoo Pharmaceutical over CGMP (manufacturing quality rules) failures at Busan plant; company suspended production.
High risk -
DrugsMark J. Savant, M.D
FDA warns clinical investigator Mark J. Savant, M.D., over protocol dosing and eligibility failures and missing informed consent in a drug trial.
High risk -
Drugs7Tabz Retail, LLC
FDA says 7Tabz Retail sells unapproved 7-OH drug products online with drug-like claims.
High risk -
FoodRoyal Diamond Imports, Inc.
FDA warned Royal Diamond Imports that its Roxy 7-OH kratom tablets are unapproved new drugs and its kratom drink mix contains an unsafe food additive.
High risk -
FoodThang Botanicals, Inc. d/b/a 7ΩHMZ, 7-OHMZ, or 7OHMZ
FDA says Thang Botanicals' 7OHMZ kratom shot, tablets, and gummies contain unsafe 7-OH and are adulterated.
High risk -
FoodMy Smoke Wholesale
My Smoke Wholesale's 777 Jackpot Alkaloids tablets are adulterated dietary supplements because 7-OH lacks adequate safety information.
High risk -
FoodA.D. Berries @ More LLC
FDA says Texas importer A.D. Berries @ More had no foreign supplier verification program for imported avocados and celery.
Medium -
DrugsLibby Laboratories, Inc.
FDA warned Libby Laboratories of Berkeley, California, that its drug manufacturing violated CGMP, including releasing a hospital antiseptic without microbial testing.
High risk -
DrugsXtreme Tools International, Inc.
FDA warned Xtreme Tools International after an inspection found manufacturing-rule failures for OTC topical drugs, including missing ingredient and batch testing.
High risk -
AnimalLystn LLC dba Answers Pet Food
FDA warned Answers Pet Food that its raw pet food contained Salmonella and Listeria and was made under insanitary conditions.
High risk -
DrugsDynamic Blending Specialists, Inc.
FDA cited Dynamic Blending Specialists for manufacturing failures in OTC drugs and an unapproved, misbranded oral antiseptic.
High risk -
DrugsExela Pharma Sciences, LLC
Exela Pharma Sciences failed CGMP (current good manufacturing practice) for sterile injectable drugs, including invalidated sterility-media tests and inaccurate microbiology records.
High risk -
BiologicsInVia Fertility Specialists, PLLC
FDA warned InVia Fertility Specialists over reproductive tissue donor eligibility and missing infectious disease testing.
High risk -
Drugswww.buynetmeds.com
FDA warned www.buynetmeds.com for selling unapproved, misbranded tapentadol and semaglutide drugs, including injectables, to U.S. consumers online.
High risk -
DrugsHealwell Homeo Private Limited
FDA warns Healwell Homeo over pest-infested drug storage and manufacturing violations.
High risk -
DrugsStaska Pharmaceuticals, Inc.
FDA warns Staska Pharmaceuticals, a Nebraska outsourcing facility, that sterile compounded drugs had contamination risks and labeling problems.
High risk -
DrugsPushclean Technology Plastik Sanayi Ve Ticaret Ltd. Sirketi
FDA warns Turkish OTC drug wipe maker Pushclean over missing finished-product and component testing.
High risk -
Drugswww.soma4ever.com
FDA warned soma4ever.com for selling unapproved and misbranded opioids, benzodiazepines, and stimulants to U.S. consumers online.
High risk -
DrugsSterling Distributors
FDA warned Florida drug wholesaler Sterling Distributors for shipping prescription drugs without licenses and ignoring a counterfeit report.
High risk